often called primary cutaneous ALCL, and it typically has a less aggressive disease course than the systemic (throughout the body) types. The characteristic features of primary cutaneous ALCL include the appearance of solitary or multiple raised, red skin lesions that are usually greater in size than a quarter that do not go away, tend to ulcerate, and may itch. These ALCL lesions are tumors, and they can appear on any part of the body, often grow very slowly, and may be present for a long time before being diagnosed. Only about 10 percent of the time does primary cutaneous ALCL extend beyond the skin to lymph nodes or organs. If this occurs, it is usually treated like systemic ALCL.
Patients with systemic ALCL are divided into two groups, depending on whether their cells produce an abnormal form of a protein 
Follow-up
Patients with lymphoma should have regular visits with a physician who is familiar with their medical history and the treatments they have received. Medical tests (such as blood tests, CT scans, and PET scans) may be required at various times during remission to evaluate the need for additional treatment.
Patients and their caregivers are encouraged to keep copies of all medical records and test results as well as information on the types, amounts, and duration of all treatments received. This documentation will be important for keeping track of any side effects resulting from treatment or potential disease recurrences.
Patient and Caregiver Support Services
A lymphoma diagnosis often triggers a range of feelings and concerns.
In addition, cancer treatment can cause physical discomfort. Oneto-one peer support programs, such as LRF's Lymphoma Support Network, connect patients and caregivers with volunteers who have experience with ALCL, similar treatments, or challenges, for mutual emotional support and encouragement. Patients and loved ones may find this information useful whether the patient is newly diagnosed, in treatment, or in remission.
